Matches in Wikidata for { <http://www.wikidata.org/entity/Q70654257> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q70654257 description "article scientifique publié en 1980" @default.
- Q70654257 description "artículu científicu espublizáu n'abril de 1980" @default.
- Q70654257 description "im April 1980 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70654257 description "scientific article published on 01 April 1980" @default.
- Q70654257 description "wetenschappelijk artikel" @default.
- Q70654257 description "наукова стаття, опублікована у квітні 1980" @default.
- Q70654257 name "Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP)" @default.
- Q70654257 name "Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP)" @default.
- Q70654257 type Item @default.
- Q70654257 label "Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP)" @default.
- Q70654257 label "Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP)" @default.
- Q70654257 prefLabel "Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP)" @default.
- Q70654257 prefLabel "Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP)" @default.
- Q70654257 P1433 Q70654257-F1981380-E588-4A9F-B340-0F1850F320D0 @default.
- Q70654257 P1476 Q70654257-18FBE631-E6C5-46ED-93D5-FEA055536D06 @default.
- Q70654257 P2093 Q70654257-00BD4A86-97F6-4063-8EDC-48B23F88DA48 @default.
- Q70654257 P2093 Q70654257-19790003-1D91-4729-B4D1-2A7A90379F5F @default.
- Q70654257 P2093 Q70654257-6C06C1BE-DC93-4DC4-8B9C-60B8A954142D @default.
- Q70654257 P2093 Q70654257-A1BB9D3C-DF74-4B38-A251-DC22D6BF519E @default.
- Q70654257 P304 Q70654257-2EAAD73C-45B5-424D-A2C7-7C35DCB8B8C0 @default.
- Q70654257 P31 Q70654257-445D9B64-D121-4F75-AD59-8600DBC5ED24 @default.
- Q70654257 P433 Q70654257-5B04BF7F-B8CD-4DFF-A578-123E726414D4 @default.
- Q70654257 P478 Q70654257-01FD40A1-D757-4BEF-B7EB-936D61CDA137 @default.
- Q70654257 P577 Q70654257-ADCE9F59-9ED0-46D1-B4E4-F0C3A5E8027D @default.
- Q70654257 P698 Q70654257-FA784435-40BA-41BB-9894-DD0ECFDE785F @default.
- Q70654257 P921 Q70654257-9193182D-A8CE-4AD6-A389-F3178CECBAD7 @default.
- Q70654257 P921 Q70654257-F7EFFA5A-376C-463D-8982-BF7F92068FCA @default.
- Q70654257 P698 7191779 @default.
- Q70654257 P1433 Q27710285 @default.
- Q70654257 P1476 "Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP)" @default.
- Q70654257 P2093 "Cormier WJ" @default.
- Q70654257 P2093 "Eagan RT" @default.
- Q70654257 P2093 "Edmonson JH" @default.
- Q70654257 P2093 "Hahn RG" @default.
- Q70654257 P304 "655-658" @default.
- Q70654257 P31 Q13442814 @default.
- Q70654257 P433 "4-5" @default.
- Q70654257 P478 "64" @default.
- Q70654257 P577 "1980-04-01T00:00:00Z" @default.
- Q70654257 P698 "7191779" @default.
- Q70654257 P921 Q18936 @default.
- Q70654257 P921 Q42824440 @default.